![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » MDS and AECL Announce Mediation Process for MAPLE Project
MDS and AECL Announce Mediation Process for MAPLE Project
March 14, 2005
MDS and Atomic Energy of Canada Limited (AECL) announced that the two companies have reached an agreement to seek a mediated resolution of the issues related to the construction, commissioning and operation of the MAPLE facilities in Chalk River, Ontario. These facilities, when commissioned, will exclusively produce medical isotopes used globally for the diagnosis and treatment of disease.
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct